AETHLON MEDICAL INC

AEMD

Aethlon Medical Inc. (AEMD) is a biotechnology company focused on developing therapeutic and diagnostic technologies for infectious disease and cancer. The company is known for its Hemopurifier, a device designed to capture and remove viruses, tumor-derived antigens, and other pathogenic substances from the blood. Aethlon aims to address unmet medical needs through its innovative biofiltration and immunotherapy-based platforms.

$3.70 +0.17 (4.57%)
🚫 AETHLON MEDICAL INC does not pay dividends

Company News

Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier® Binds to Extracellular Vesicles in Long COVID patient samples and Decreases Inflammatory microRNAs
Benzinga • Prnewswire • December 2, 2025

Aethlon Medical published preclinical study showing their Hemopurifier device can bind and remove extracellular vesicles from Long COVID patient samples, potentially decreasing inflammatory microRNAs and offering a novel therapeutic approach.

Correction to Previous Release: “Promeza MG Works with AETH to Support its LS25 Predicación y Migración Conference”
GlobeNewswire Inc. • Betty Meza • September 30, 2025

Promeza MG has been contracted by AETH to provide marketing services for a theological conference addressing migration, preaching, and pastoral care, taking place in October 2025 at Life Pacific University.

Strategies for Trading Options With Penny Stocks
PennyStocks • J. Phillip • June 7, 2024

Trading options with penny stocks? Here's what you need to kno The post Strategies for Trading Options With Penny Stocks appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Wall Street Breakfast: What Moved Markets
Seeking Alpha • Wall Street Breakfast • June 12, 2021

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify.

Related Companies